Study Stopped
COVID-19
Implementation of an Infusion Management Scheme to Improve Patient Outcome in Tertiary Children's Hospitals
1 other identifier
interventional
1,000
1 country
9
Brief Summary
This study is a multi-center before-after trial design. The object is to observe whether the incidence of central line associated blood stream infection(CLABSI) will tend to descend compared with retrospective electronic medical record data after implementation of an infusion management scheme which comes form " Clinical Practice Guideline on Infusion Therapy in Children " .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2022
Typical duration for not_applicable
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2021
CompletedFirst Posted
Study publicly available on registry
December 9, 2021
CompletedStudy Start
First participant enrolled
March 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedNovember 4, 2024
October 1, 2024
2.7 years
November 26, 2021
October 31, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of CLABSI
CLABSI diagnostic criteria requires that a central line is in situ at the time of or within 48 hours; children with a central line have fever (over 38℃), chills, hypotension or mental state changes; there is no alternate source of bloodstream infection. Apart from the above three necessary requirements, CLABSI diagnosis could be accompanied by two positive blood cultures drawn from a peripheral vein and a CVAD, two positive blood cultures drawn from different CVADs, one positive blood culture from a CVAD with a planned specific antimicrobial therapy or common skin contamination bacteria cultured (eg. Coagulase-negative Staphylococci, diphtheroids, Bacillus or Micrococcus). Incidence of CLABSI = (case numbers of CLABSI)/(Catheter Days per Month)×1000‰.
During the 6-month implementation
Secondary Outcomes (3)
Changes of Inspection rate of suspected CLABSI samples
From baseline to the end of the 6-month implementation
Incidece of infiltration (of Grade2 or higher) and/or extravasation
During the 6-month implementation
Changes of the scores of readiness of internal context
From baseline to the end of the 6-month implementation
Study Arms (1)
Infusion management scheme
EXPERIMENTALTo implement infusion management scheme, then observe the continuous changes.
Interventions
* To set up a pediatric intravenous infusion team; * To form standardized procedures by carrying out a quality improvement program in collecting and sending samples for inspection once suspected CLABSI occurs (1 month for training and 3 months for continuous improvement ); providing infusion training curriculums to nurses in forms of lectures, group discussions, operation demonstrations, and scenario simulations, holding practice review meeting with them; providing elements to caregivers of educational leaflet, nurse-provided education during patients' infusion therapy( 6-month implementation); * To observe the continued daily infusion practice in 6 months.
Eligibility Criteria
You may qualify if:
- A tertiary children's hospital with more than 300 beds
- The vice president in charge of nursing affairs, the director of nursing department and the director of hospital infection control department all agree in participating in this study with written permission, which include total acceptance of infusion management scheme and outcome indicators report as required
- To obtain the approval from Ethics Committee of the hospital
- Hospitalized children aged 0\~18 years
- Catheterization and maintenance in the same center
- The indwelling time is longer than 48h
You may not qualify if:
- The vice president in charge of nursing affairs or the director of nursing department inform the researcher to withdraw from this study with written form and should clear reasons
- The number of cases for suspected CLABSI sample actually submitted for inspection / The number of cases for suspected CLABSI sample should submitted for inspection\<0.9
- The awareness rate of infusion management scheme in clinical nurses is less than 90% and the qualification rate of the practice examination in clinical nurses is less than90% during inspection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Children's Hospital of Fudan Universitylead
- Xiamen Children's Hospitalcollaborator
- Anhui Provincial Children's Hospitalcollaborator
- Dalian women and children's medical groupcollaborator
- First Affiliated Hospital of Guangxi Medical Universitycollaborator
- Qidong Women's and Children's Healthcollaborator
- Chengdu Women's and Children's Central Hospitalcollaborator
- Hunan Children's Hospitalcollaborator
- Tongji Hospitalcollaborator
Study Sites (9)
Anhui Provincial Children's Hospital
Hefei, Anhui, China
Xiamen Children's Hospital
Xiamen, Fujian, China
First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi, China
Tongji Hospital
Wuhan, Hubei, China
Hunan Children's Hospital
Changsha, Hunan, China
Qidong Women's and Children's Health
Qidong, Jiangsu, China
Dalian women and children's medical group
Dalian, Liaoning, China
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, 201102, China
Chengdu Women's and Children's Central Hospital
Chengdu, Sichuan, China
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2021
First Posted
December 9, 2021
Study Start
March 7, 2022
Primary Completion
November 1, 2024
Study Completion
November 1, 2024
Last Updated
November 4, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share